G. Thangavelu

发表

Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

C. Anderson, G. Thangavelu, C. Smolarchuk, 2010, Self/nonself.

Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses.

S. Furlan, D. Munn, J. Serody, 2020, Blood.

Inhibition of Inositol kinase B controls acute and chronic graft-versus-host disease.

J. Ritz, D. Munn, J. Serody, 2019, Blood.

PD‐1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells

L. Boon, C. Ewen, K. K. Ellestad, 2014, European journal of immunology.

Retinoic acid signaling acts as a rheostat to balance Treg function

S. Furlan, D. Munn, H. Chi, 2022, Cellular & Molecular Immunology.

Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1

L. Boon, K. K. Ellestad, Y. Haile, 2018, Front. Immunol..

Control of In Vivo Collateral Damage Generated by T Cell Immunity

L. Boon, R. Gill, K. K. Ellestad, 2013, The Journal of Immunology.

Generated by T Cell Immunity Control of In Vivo Collateral Damage

L. Boon, R. Gill, K. K. Ellestad, 2013 .

The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease

Jason S. Mitchell, D. Munn, J. Serody, 2018, The Journal of clinical investigation.

Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.

D. Munn, J. Serody, J. Allison, 2019, JCI insight.

Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis.

C. Ewen, R. Uwiera, C. Anderson, 2011, Journal of autoimmunity.

The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants.

L. Boon, K. Murphy, H. Yagita, 2011, Immunobiology.

An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation.

C. Anderson, G. Thangavelu, 2011, Future oncology.

Divide and conquer: Blocking graft versus host but not graft versus leukemia T cells with agonist BTLA co-inhibitory signals.

C. Anderson, G. Thangavelu, 2011, Chimerism.

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses

J. Wagner, B. Blazar, Mark J. Osborn, 2022, JCI insight.

Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.

R. Negrin, B. Blazar, Jing Du, 2017, Blood.

CD8 T Cells Target Antigen Cross-Presented by Bone Marrow Derived Cells to Induce Bystander Rejection of Grafts Lacking the Cognate Peptide-MHC

L. Boon, D. Al-Adra, K. K. Ellestad, 2022, Cell transplantation.

Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality

P. Chambon, D. Munn, J. Serody, 2019, The Journal of Immunology.

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease

J. Rathmell, B. Blazar, P. Sage, 2021, Frontiers in Immunology.

Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GvHD.

D. Munn, J. Serody, S. Jameson, 2019, Blood.

Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function

E. Pearce, K. Grzes, M. Corrado, 2019, Cell metabolism.

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease

B. Blazar, G. Thangavelu, 2019, Front. Immunol..

Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.

J. Serody, D. Littman, G. Hill, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.

G. Freeman, S. Furlan, D. Munn, 2016, The Journal of clinical investigation.

Tackling cancer cell dormancy: Insights from immune models, and transplantation.

T. Bakács, A. Corthay, C. Anderson, 2021, Seminars in cancer biology.

Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease

B. Blazar, Jing Du, R. Flynn, 2022, Frontiers in Immunology.

BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice

K. Murphy, A. Shapiro, W. Hancock, 2009, Journal of leukocyte biology.

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice.

S. Furlan, J. Tolar, Y. Refaeli, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.

J. Zehnder, R. Negrin, B. Blazar, 2020, Blood advances.

BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.

J. Qi, J. Bradner, J. Ritz, 2022, Blood.

Recipient-speci ﬁ c T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

J. Zehnder, R. Negrin, B. Blazar, 2020 .

Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo.

J. Tolar, C. Eide, R. Negrin, 2022, Blood.

Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage

A. Hanash, G. Thangavelu, M. Calafiore, 2024, The Journal of clinical investigation.

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants

H. Cheroutre, K. K. Ellestad, K. Kakugawa, 2024, bioRxiv.